{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:35:54Z","timestamp":1789014954111,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1149990,"],"award-info":[{"award-number":["GNT1149990,"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135851"],"award-info":[{"award-number":["1135851"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2026490"],"award-info":[{"award-number":["2026490"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016732"],"award-info":[{"award-number":["2016732"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110406-73-RGRL"],"award-info":[{"award-number":["110406-73-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110406-73-RGRL"],"award-info":[{"award-number":["110406-73-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110406-73-RGRL"],"award-info":[{"award-number":["110406-73-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110406-73-RGRL"],"award-info":[{"award-number":["110406-73-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI164560"],"award-info":[{"award-number":["UM1AI164560"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cass Foundation, Australian Centre for HIV and hepatitis virology research (ACH2\/ACH4), Harold & Cora Brennen Benevolent Trust"},{"name":"The Netherlands Organisation for Scientific Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    T cells are critically important to many diseases but are traditionally difficult to transfect. We hypothesise that the delivery of therapeutic cargo to T cells can be improved by targeting nanoparticles to surface receptors that undergo rapid receptor-mediated endocytosis. Using an internalisation assay that labelled intracellular and surface proteins with different fluorophores, we find that CD2 and CD7 exhibit significantly higher internalisation than other T cell receptors, such as CD3 or CD4. Targeting CD2 and CD7 improves nanoparticle internalisation by non-stimulated, primary CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and enhances the specificity of association to CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Similarly, functionalising mRNA-lipid nanoparticles with antibodies targeting CD2 or CD7 enhances mRNA delivery to CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells in vitro. Importantly, targeting CD2 or CD7 enables efficient lipid nanoparticle-mediated delivery of mRNA to T cells in blood and lymphoid tissue in vivo, demonstrating that targeting T cell receptor endocytosis can enhance nanoparticle-mediated drug delivery to T cells.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-74981-2","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:15:49Z","timestamp":1782922549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4+ T cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-7904","authenticated-orcid":false,"given":"Paula M.","family":"Cevaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-4343","authenticated-orcid":false,"given":"Abdalla","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-3021","authenticated-orcid":false,"given":"Marcel","family":"Doerflinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cortez-Jugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-5117","authenticated-orcid":false,"given":"Moore Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Dayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-4975","authenticated-orcid":false,"given":"Liana","family":"Mackiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-5813","authenticated-orcid":false,"given":"Matthew","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gubser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-3428","authenticated-orcid":false,"given":"Ren\u00e9 P. M.","family":"Lafleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4316-3910","authenticated-orcid":false,"given":"Robert","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-4515","authenticated-orcid":false,"given":"Angus P. R.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0197-497X","authenticated-orcid":false,"given":"Frank","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-1577","authenticated-orcid":false,"given":"Jori","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-8241","authenticated-orcid":false,"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"74981_CR1","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014\u201316014 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"74981_CR2","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1021\/acsnano.0c09514","volume":"15","author":"PM Cevaal","year":"2021","unstructured":"Cevaal, P. M. et al. In vivo T cell-targeting nanoparticle drug delivery systems: considerations for rational design. ACS Nano 15, 3736\u20133753 (2021).","journal-title":"ACS Nano"},{"key":"74981_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar, B. V., Connors, T. J. & Farber, D. L. Human T cell development, localization, and function throughout life. Immunity 48, 202\u2013213 (2018).","journal-title":"Immunity"},{"key":"74981_CR4","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger, T. & Abdul-Hay, M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 7, e577\u2013e577 (2017).","journal-title":"Blood Cancer J."},{"key":"74981_CR5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","volume":"21","author":"A Hirons","year":"2021","unstructured":"Hirons, A., Khoury, G. & Purcell, D. F. J. Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent. Lancet Infect. Dis. 21, e2\u2013e10 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"74981_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","volume":"27","author":"LB Cohn","year":"2020","unstructured":"Cohn, L. B., Chomont, N. & Deeks, S. G. The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies. Cell Host Microbe 27, 519\u2013530 (2020).","journal-title":"Cell Host Microbe"},{"key":"74981_CR7","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","volume":"94","author":"T-W Chun","year":"1997","unstructured":"Chun, T.-W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. Usa. 94, 13193\u201313197 (1997).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"74981_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295\u20131300 (1997).","journal-title":"Science"},{"key":"74981_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/jmp.12613","volume":"51","author":"K Tanaka","year":"2022","unstructured":"Tanaka, K., Kim, Y., Roche, M. & Lewin, S. R. The role of latency reversal in HIV cure strategies. J. Med. Primatol. 51, 278\u2013283 (2022).","journal-title":"J. Med. Primatol."},{"key":"74981_CR10","doi-asserted-by":"publisher","first-page":"e18270","DOI":"10.1371\/journal.pone.0018270","volume":"6","author":"M Kovochich","year":"2011","unstructured":"Kovochich, M., Marsden, M. D. & Zack, J. A. Activation of latent HIV using drug-loaded nanoparticles. PLoS One 6, e18270 (2011).","journal-title":"PLoS One"},{"key":"74981_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/mt.2009.271","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim, S. S. et al. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol. Ther. 18, 370\u2013376 (2010).","journal-title":"Mol. Ther."},{"key":"74981_CR12","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jconrel.2011.08.089","volume":"152","author":"S Choi","year":"2011","unstructured":"Choi, S., Lee, J., Kumar, P., Lee, K. Y. & Lee, S. K. Single chain variable fragment CD7 antibody conjugated PLGA\/HDAC inhibitor immuno-nanoparticles: developing human T cell-specific nano-technology for delivery of therapeutic drugs targeting latent HIV. J. Control. Release 152, e9\u2013e10 (2011).","journal-title":"J. Control. Release"},{"key":"74981_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"74981_CR14","doi-asserted-by":"crossref","unstructured":"Charpentier, J. C. et al. Macropinocytosis drives T cell growth by sustaining the activation of mTORC1. Nat. Commun.s 11, 180 (2020).","DOI":"10.1038\/s41467-019-13997-3"},{"key":"74981_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm3151","volume":"12","author":"HT McMahon","year":"2011","unstructured":"McMahon, H. T. & Boucrot, E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12, 517\u2013533 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"74981_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1242\/jcs.1985.Supplement_3.17","volume":"Suppl 3","author":"CR Hopkins","year":"1985","unstructured":"Hopkins, C. R., Miller, K. & Beardmore, J. M. Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. J. Cell Sci. Suppl 3, 173\u2013186 (1985).","journal-title":"J. Cell Sci."},{"key":"74981_CR17","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","volume":"29","author":"I Tombacz","year":"2021","unstructured":"Tombacz, I. et al. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Mol. Ther. 29, 3293\u20133304 (2021).","journal-title":"Mol. Ther."},{"key":"74981_CR18","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1039\/C6NR00506C","volume":"8","author":"JJ Glass","year":"2016","unstructured":"Glass, J. J. et al. Human immune cell targeting of protein nanoparticles-caveospheres. Nanoscale 8, 8255\u20138265 (2016).","journal-title":"Nanoscale"},{"key":"74981_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.296.7.815","volume":"296","author":"MM Lederman","year":"2006","unstructured":"Lederman, M. M., Penn-Nicholson, A., Cho, M. & Mosier, D. Biology of CCR5 and its role in HIV infection and treatment. J. Am. Med. Assoc. 296, 815\u2013826 (2006).","journal-title":"J. Am. Med. Assoc."},{"key":"74981_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1084\/jem.173.3.575","volume":"173","author":"A Pelchen-Matthews","year":"1991","unstructured":"Pelchen-Matthews, A., Armes, J. E., Griffiths, G. & Marsh, M. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J. Exp. Med. 173, 575\u2013587 (1991).","journal-title":"J. Exp. Med."},{"key":"74981_CR21","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1021\/nl051264s","volume":"5","author":"A Khaled","year":"2005","unstructured":"Khaled, A., Guo, S., Li, F. & Guo, P. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett. 5, 1797\u20131808 (2005).","journal-title":"Nano Lett."},{"key":"74981_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/QAD.0000000000001029","volume":"30","author":"G Khoury","year":"2016","unstructured":"Khoury, G. et al. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4R T cells in HIV-infected individuals on antiretroviral therapy. AIDS 30, 1511\u20131520 (2016).","journal-title":"AIDS"},{"key":"74981_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893\u2013900 (2009).","journal-title":"Nat. Med."},{"key":"74981_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","volume":"210","author":"M Perreau","year":"2013","unstructured":"Perreau, M. et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J. Exp. Med. 210, 143\u2013156 (2013).","journal-title":"J. Exp. Med."},{"key":"74981_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAD.0000000000001309","volume":"31","author":"A Gosselin","year":"2017","unstructured":"Gosselin, A. et al. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy. AIDS 31, 35\u201348 (2017).","journal-title":"AIDS"},{"key":"74981_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.immuni.2017.09.018","volume":"47","author":"CS McGary","year":"2017","unstructured":"McGary, C. S. et al. CTLA-4+PD-1\u2212 memory CD4+ T cells critically contribute to viral persistence in antiretroviral therapy-suppressed, SIV-infected rhesus macaques. Immunity 47, 776\u2013788.e775 (2017).","journal-title":"Immunity"},{"key":"74981_CR27","doi-asserted-by":"crossref","unstructured":"Neidleman, J. et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. eLife 9, e60933 (2020).","DOI":"10.7554\/eLife.60933"},{"key":"74981_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jconrel.2013.05.037","volume":"172","author":"Y Zheng","year":"2013","unstructured":"Zheng, Y. et al. In vivo targeting of adoptively transferred T-cells with antibody-and cytokine-conjugated liposomes. J. Control. Release 172, 426\u2013435 (2013).","journal-title":"J. Control. Release"},{"key":"74981_CR29","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1073\/pnas.83.5.1463","volume":"83","author":"AM Weissman","year":"1986","unstructured":"Weissman, A. M. et al. Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc. Natl. Acad. Sci. Usa. 83, 1463\u20131466 (1986).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"74981_CR30","doi-asserted-by":"publisher","first-page":"9429","DOI":"10.1074\/jbc.M111.304329","volume":"287","author":"OS Qureshi","year":"2012","unstructured":"Qureshi, O. S. et al. Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation. J. Biol. Chem. 287, 9429\u20139440 (2012).","journal-title":"J. Biol. Chem."},{"key":"74981_CR31","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","volume":"22","author":"R Banga","year":"2016","unstructured":"Banga, R. et al. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat. Med. 22, 754\u2013761 (2016).","journal-title":"Nat. Med."},{"key":"74981_CR32","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/QAD.0000000000001849","volume":"32","author":"VA Evans","year":"2018","unstructured":"Evans, V. A. et al. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency. AIDS 32, 1491\u20131497 (2018).","journal-title":"AIDS"},{"key":"74981_CR33","doi-asserted-by":"crossref","unstructured":"Fromentin, R. et al. CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. PLoS Pathogens 12, e1005761 (2016).","DOI":"10.1371\/journal.ppat.1005761"},{"key":"74981_CR34","doi-asserted-by":"crossref","unstructured":"Llewellyn, G. N. et al. Humanized mouse model of HIV-1 latency with enrichment of latent virus in PD-1(+) and TIGIT(+) CD4 T cells. J. Virol. 93, e02086 (2019).","DOI":"10.1128\/JVI.02086-18"},{"key":"74981_CR35","doi-asserted-by":"publisher","first-page":"e1007619","DOI":"10.1371\/journal.ppat.1007619","volume":"15","author":"M Pardons","year":"2019","unstructured":"Pardons, M. et al. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection. PLoS Pathog. 15, e1007619 (2019).","journal-title":"PLoS Pathog."},{"key":"74981_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1083\/jcb.97.2.329","volume":"97","author":"C Harding","year":"1983","unstructured":"Harding, C., Heuser, J. & Stahl, P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329\u2013339 (1983).","journal-title":"J. Cell Biol."},{"key":"74981_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00232-014-9637-0","volume":"247","author":"S Tortorella","year":"2014","unstructured":"Tortorella, S. & Karagiannis, T. C. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy. J. Membr. Biol. 247, 291\u2013307 (2014).","journal-title":"J. Membr. Biol."},{"key":"74981_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar, P. et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577\u2013586 (2008).","journal-title":"Cell"},{"key":"74981_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S1074-7613(00)00066-2","volume":"13","author":"H Liu","year":"2000","unstructured":"Liu, H., Rhodes, M., Wiest, D. L. & Vignali, D. A. A. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 13, 665\u2013675 (2000).","journal-title":"Immunity"},{"key":"74981_CR40","doi-asserted-by":"publisher","first-page":"1805740","DOI":"10.1002\/adma.201805740","volume":"31","author":"R Cai","year":"2019","unstructured":"Cai, R. & Chen, C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv. Mater. 31, 1805740\u20131805740 (2019).","journal-title":"Adv. Mater."},{"key":"74981_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acsmacrolett.7b00229","volume":"6","author":"JJ Glass","year":"2017","unstructured":"Glass, J. J. et al. Charge has a marked influence on hyperbranched polymer nanoparticle association in whole human blood. ACS Macro Lett. 6, 586\u2013592 (2017).","journal-title":"ACS Macro Lett."},{"key":"74981_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101178","volume":"4","author":"P Arandjelovic","year":"2023","unstructured":"Arandjelovic, P. et al. Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice. Cell Rep. Med. 4, 101178 (2023).","journal-title":"Cell Rep. Med."},{"key":"74981_CR43","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477\u20136489 (2005).","journal-title":"J. Immunol."},{"key":"74981_CR44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","volume":"20","author":"MZ Chen","year":"2025","unstructured":"Chen, M. Z. et al. A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles. Nat. Nanotechnol. 20, 1273\u20131284 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"74981_CR45","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.ymthe.2017.03.001","volume":"25","author":"S Mizrahy","year":"2017","unstructured":"Mizrahy, S., Hazan-Halevy, I., Dammes, N., Landesman-Milo, D. & Peer, D. Current progress in non-viral RNAi-based delivery strategies to lymphocytes. Mol. Ther. 25, 1491\u20131500 (2017).","journal-title":"Mol. Ther."},{"key":"74981_CR46","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1021\/bc2006219","volume":"23","author":"J Lee","year":"2012","unstructured":"Lee, J. et al. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles. Bioconjugate Chem. 23, 1174\u20131180 (2012).","journal-title":"Bioconjugate Chem."},{"key":"74981_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cyto.990170404","volume":"17","author":"ES Van Amersfoort","year":"1994","unstructured":"Van Amersfoort, E. S. & Van Strijp, J. A. G. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17, 294\u2013301 (1994).","journal-title":"Cytometry"},{"key":"74981_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1590\/1414-431X20143437","volume":"47","author":"BA Avelar-Freitas","year":"2014","unstructured":"Avelar-Freitas, B. A. et al. Trypan blue exclusion assay by flow cytometry. Braz. J. Med. Biol. Res. 47, 307\u2013315 (2014).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"74981_CR49","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1093\/nar\/19.20.5543","volume":"19","author":"Y Shoji","year":"1991","unstructured":"Shoji, Y., Akhtar, S., Periasamy, A., Herman, B. & Juliano, R. L. Mechansism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res. 19, 5543\u20135550 (1991).","journal-title":"Nucleic Acids Res."},{"key":"74981_CR50","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s11095-016-1984-3","volume":"33","author":"SK Mann","year":"2016","unstructured":"Mann, S. K., Czuba, E., Selby, L. I., Such, G. K. & Johnston, A. P. R. Quantifying Nanoparticle Internalization Using a High Throughput Internalization Assay. Pharm. Res. 33, 2421\u20132432 (2016).","journal-title":"Pharm. Res."},{"key":"74981_CR51","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1002\/anie.201301243","volume":"52","author":"H Liu","year":"2013","unstructured":"Liu, H. & Johnston, A. P. R. A programmable sensor to probe the internalization of proteins and nanoparticles in live cells. Angew. Chem. Int. Ed. 52, 5744\u20135748 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74981_CR52","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1021\/acssensors.8b00219","volume":"3","author":"LI Selby","year":"2018","unstructured":"Selby, L. I., Aurelio, L., Yuen, D., Graham, B. & Johnston, A. P. R. Quantifying cellular internalization with a fluorescent click sensor. ACS Sens. 3, 1182\u20131189 (2018).","journal-title":"ACS Sens."},{"key":"74981_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-3606-9_15","volume":"1423","author":"H Liu","year":"2016","unstructured":"Liu, H., Dumont, C., Johnston, A. P. R. & Mintern, J. D. Analysis of intracellular trafficking of dendritic cell receptors for antigen targeting. Methods Mol. Biol. 1423, 199\u2013209 (2016).","journal-title":"Methods Mol. Biol."},{"key":"74981_CR54","doi-asserted-by":"publisher","unstructured":"Cevaal, P. M., Roche, M., Lewin, S. R., Caruso, F. & Faria, M. Experimental quantification of interactions between drug delivery systems and cells in vitro: a guide for preclinical nanomedicine evaluation. J. Vis. Exp. https:\/\/doi.org\/10.3791\/64259 (2022).","DOI":"10.3791\/64259"},{"key":"74981_CR55","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria, M. et al. Minimum information reporting in bio\u2013nano experimental literature. Nat. Nanotechnol. 13, 777\u2013785 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"74981_CR56","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1021\/acs.chemmater.1c02369","volume":"33","author":"M Faria","year":"2021","unstructured":"Faria, M., Johnston, S. T., Mitchell, A. J., Crampin, E. & Caruso, F. Bio-nano science: better metrics would accelerate progress. Chem. Mater. 33, 7613\u20137619 (2021).","journal-title":"Chem. Mater."},{"key":"74981_CR57","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1002\/adma.200801826","volume":"20","author":"R De Rose","year":"2008","unstructured":"De Rose, R. et al. Binding, internalization, and antigen presentation of vaccine-loaded nanoengineered capsules in blood. Adv. Mater. 20, 4698\u20134703 (2008).","journal-title":"Adv. Mater."},{"key":"74981_CR58","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/acsami.9b20993","volume":"12","author":"KW Yong","year":"2020","unstructured":"Yong, K. W., Yuen, D., Chen, M. Z. & Johnston, A. P. R. Engineering the orientation, density, and flexibility of single-domain antibodies on nanoparticles to improve cell targeting. ACS Appl. Mater. Interfaces 12, 5593\u20135600 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"74981_CR59","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1128\/JVI.01297-13","volume":"87","author":"M Iglesias-Ussel","year":"2013","unstructured":"Iglesias-Ussel, M., Vandergeeten, C., Marchionni, L., Chomont, N. & Romerio, F. High Levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. J. Virol. 87, 9148\u20139158 (2013).","journal-title":"J. Virol."},{"key":"74981_CR60","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3389\/fimmu.2018.02552","volume":"9","author":"AG Tomalka","year":"2018","unstructured":"Tomalka, A. G., Resto-Garay, I., Campbell, K. S. & Popkin, D. L. In vitro evidence that combination therapy with CD16-bearing NK-92 cells and FDA-approved alefacept can selectively target the latent HIV reservoir in CD4+ CD2hi memory T cells. Front. Immunol. 9, 2552\u20132552 (2018).","journal-title":"Front. Immunol."},{"key":"74981_CR61","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nnano.2017.57","volume":"12","author":"TT Smith","year":"2017","unstructured":"Smith, T. T. et al. In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nat. Nanotechnol. 12, 813\u2013822 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"74981_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100766","volume":"3","author":"TA Rasmussen","year":"2022","unstructured":"Rasmussen, T. A. et al. Memory CD4(+) T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency. Cell Rep. Med. 3, 100766 (2022).","journal-title":"Cell Rep. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74981-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:02:17Z","timestamp":1786532537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74981-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74981"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74981-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.R.L. has received honoraria for participation in advisory boards for Gilead, Viiv Healthcare, Merck, AbbVie, Esfam, Immunocore and First Health. She has received funding from Gilead and Merck for investigator-initiated research projects. P.M.C., S.K., M.R., J.S. and S.R.L. are named investigators on two patent applications related to this work. M.Z.C. and A.P.R.J. are co-inventors on two further patents related to aspects of this work. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8204"}}